Siegel, Sonja
Giese, Sabrina
Honegger, Jürgen
Friedel, Anna Lena
Grzywotz, Agnieszka
Wrede, Karsten Henning
Sure, Ulrich
Unger, Nicole
Kreitschmann-Andermahr, Ilonka http://orcid.org/0000-0002-6389-0261
Funding for this research was provided by:
Universitätsklinikum Essen
Article History
Accepted: 30 April 2024
First Online: 24 May 2024
Declarations
:
: IKA, NU and JH received research support and/or travel grants and/or lecture or advisory board honoraria from Recordati Rare Diseases GmbH Germany, IPSEN Pharma GmbH Germany, Advanz Pharma GmbH, Pfizer Pharma GmbH Germany and Pfizer Co., all of which are manufactures of acromegaly medications. SS received research support and/or travel grants and/or consultation fees from IPSEN Pharma GmbH Germany, Advanz Pharma GmbH, Pfizer Pharma GmbH Germany and Pfizer Co. ALF, US, KHW and SG declare to have no conflict of interest in relation to the content of this article.